Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria (Q34064209)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

multicenter clinical trial

0 references

multiple sclerosis

0 references

magnetic resonance imaging

0 references

methylprednisolone

1 reference

based on heuristic

inferred from title

author name string

Edan G

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Miller D

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Clanet M

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Confavreux C

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lyon-Caen O

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lubetzki C

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Brochet B

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Berry I

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Rolland Y

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Froment JC

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Cabanis E

11

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Iba-Zizen MT

12

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Gandon JM

13

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Lai HM

14

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Moseley I

15

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sabouraud O

16

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

1 February 1997

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Journal of Neurology, Neurosurgery and Psychiatry

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

62

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

112-118

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

describes a project that uses

magnetic resonance imaging

1 reference

based on heuristic

inferred from title

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Guidelines for the use of magnetic resonance techniques in monitoring the treatment of multiple sclerosis. US National MS Society Task Force.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

An open-trial evaluation of mitoxantrone in the treatment of progressive MS.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Suppression of experimental allergic encephalomyelitis by mitoxantrone.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Selective immunomodulation by the antineoplastic agent mitoxantrone. II. Nonspecific adherent suppressor cells derived from mitoxantrone-treated mice.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Cognitive change following MPTP exposure.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

The efficacy of azathioprine in relapsing-remitting multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Magnetic resonance imaging in monitoring the treatment of multiple sclerosis: concerted action guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effect

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

EDMUS, a European database for multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Treatment of multiple sclerosis with mitoxantrone

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Using gadolinium-enhanced magnetic resonance imaging lesions to monitor disease activity in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

5 July 2018

Preliminary evidence from magnetic resonance imaging for reduction in disease activity after lymphocyte depletion in multiple sclerosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Low-dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Blood-brain barrier disruption on contrast-enhanced MRI in patients with mild relapsing-remitting multiple sclerosis: relationship to course, gender, and age.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=486720

28 October 2018

Clinical safety and tolerance of mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mitoxantrone: an overview of safety and toxicity

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antitumor agent mitoxantrone binds cooperatively to DNA: evidence for heterogeneity in DNA conformation

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selective immunomodulation by the antineoplastic agent mitoxantrone. I. Suppression of B lymphocyte function

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional suppression, therapy after onset and prevention of relapses in experimental allergic encephalomyelitis by mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of acute and relapsing experimental allergic encephalomyelitis with mitoxantrone

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclosporine versus azathioprine in the long-term treatment of multiple sclerosis--results of the German multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gadolinium enhancement increases the sensitivity of MRI in detecting disease activity in multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A Controlled Trial of Mitoxantrone in Multiple Sclerosis: Serial MRI Evaluation at One Year

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of interferon-beta on blood-brain barrier disruptions demonstrated by contrast-enhanced magnetic resonance imaging in relapsing-remitting multiple sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Noninvasive Assessment of Mitoxantrone Cardiotoxicity in Relapsing Remitting Multiple Sclerosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/9048709

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/JNNP.62.2.112

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34064209&oldid=1877326209"